About
Stimalia develops a percutaneous bioelectronic implant called TraumaTone that targets the stellate ganglion to treat PTSD by modulating the body's sympathetic nervous system without drugs.
Explore Stimalia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.